GM2/GM3 controls the organizational status of CD82/Met microdomains: further studies in GM2/GM3 complexation

Glycoconj J. 2022 Oct;39(5):653-661. doi: 10.1007/s10719-022-10061-z. Epub 2022 May 10.

Abstract

At cell surface gangliosides might associate with signal transducers proteins, grown factor receptors, integrins, small G-proteins and tetraspanins establishing microdomains, which play important role in cell adhesion, cell activation, motility, and growth. Previously, we reported that GM2 and GM3 form a heterodimer that interacts with the tetraspanin CD82, controlling epithelial cell mobility by inhibiting integrin-hepatocyte growth factor-induced cMet tyrosine kinase signaling. By using molecular dynamics simulations to study the molecular basis of GM2/GM3 interaction we demonstrate, here, that intracellular levels of Ca2+ mediate GM2/GM3 complexation via electrostatic interaction with their carboxyl groups, while hydrogen bonds between the ceramide groups likely aid stabilizing the complex. The presence of GM2/GM3 complex alters localization of CD82 on cell surface and therefore downstream signalization. These data contribute for the knowledge of how glycosylation may control signal transduction and phenotypic changes.

Keywords: CD82; Cancer; Glycosphingolipids; Met; Microdomains; Tetraspanin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Adhesion
  • Cell Movement
  • G(M3) Ganglioside*
  • Kangai-1 Protein* / metabolism
  • Signal Transduction

Substances

  • G(M3) Ganglioside
  • Kangai-1 Protein